These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16493053)

  • 1. Evidence that complement protein C1q interacts with C-reactive protein through its globular head region.
    McGrath FD; Brouwer MC; Arlaud GJ; Daha MR; Hack CE; Roos A
    J Immunol; 2006 Mar; 176(5):2950-7. PubMed ID: 16493053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
    Jiang HX; Siegel JN; Gewurz H
    J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain.
    Jiang H; Robey FA; Gewurz H
    J Exp Med; 1992 May; 175(5):1373-9. PubMed ID: 1569403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP.
    Radanova M; Vasilev V; Deliyska B; Kishore U; Ikonomov V; Ivanova D
    Immunobiology; 2012 Jul; 217(7):684-91. PubMed ID: 22209113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
    Duvall MR; Hwang HY; Boackle RJ
    Immunobiology; 2010 May; 215(5):395-405. PubMed ID: 19586684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heme interacts with c1q and inhibits the classical complement pathway.
    Roumenina LT; Radanova M; Atanasov BP; Popov KT; Kaveri SV; Lacroix-Desmazes S; Frémeaux-Bacchi V; Dimitrov JD
    J Biol Chem; 2011 May; 286(18):16459-69. PubMed ID: 21454703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of anti-C1q antibodies and anti-C1q globular head domain antibodies in sera from Chinese patients with lupus nephritis.
    Tan Y; Zhou W; Yu F; Fang Q; Yang HZ; Zhao MH
    Mol Immunol; 2009 Jul; 46(11-12):2178-82. PubMed ID: 19481805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains.
    Kishore U; Gupta SK; Perdikoulis MV; Kojouharova MS; Urban BC; Reid KB
    J Immunol; 2003 Jul; 171(2):812-20. PubMed ID: 12847249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of ligand-binding sites on human C1q globular head region using recombinant globular head fragments and single-chain antibodies.
    Kojouharova MS; Tsacheva IG; Tchorbadjieva MI; Reid KB; Kishore U
    Biochim Biophys Acta; 2003 Nov; 1652(1):64-74. PubMed ID: 14580997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction.
    Sjöwall C; Wetterö J; Bengtsson T; Askendal A; Almroth G; Skogh T; Tengvall P
    Biochem Biophys Res Commun; 2007 Jan; 352(1):251-8. PubMed ID: 17113035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation.
    Kovacs H; Campbell ID; Strong P; Johnson S; Ward FJ; Reid KB; Eggleton P
    Biochemistry; 1998 Dec; 37(51):17865-74. PubMed ID: 9922153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.
    Nauta AJ; Bottazzi B; Mantovani A; Salvatori G; Kishore U; Schwaeble WJ; Gingras AR; Tzima S; Vivanco F; Egido J; Tijsma O; Hack EC; Daha MR; Roos A
    Eur J Immunol; 2003 Feb; 33(2):465-73. PubMed ID: 12645945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties.
    Gaboriaud C; Juanhuix J; Gruez A; Lacroix M; Darnault C; Pignol D; Verger D; Fontecilla-Camps JC; Arlaud GJ
    J Biol Chem; 2003 Nov; 278(47):46974-82. PubMed ID: 12960167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of human C1q with IgG and IgM: revisited.
    Gadjeva MG; Rouseva MM; Zlatarova AS; Reid KB; Kishore U; Kojouharova MS
    Biochemistry; 2008 Dec; 47(49):13093-102. PubMed ID: 19006321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the interactions between C-reactive protein and complement proteins.
    Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z
    Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of a recombinant form of the C-terminal, globular head region of the B-chain of human serum complement protein, C1q.
    Kishore U; Leigh LE; Eggleton P; Strong P; Perdikoulis MV; Willis AC; Reid KB
    Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):27-32. PubMed ID: 9639558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the globular domain of human C1q with Salmonella typhimurium lipopolysaccharide.
    Roumenina LT; Popov KT; Bureeva SV; Kojouharova M; Gadjeva M; Rabheru S; Thakrar R; Kaplun A; Kishore U
    Biochim Biophys Acta; 2008 Sep; 1784(9):1271-6. PubMed ID: 18513495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C1q-target proteins recognition is inhibited by electric moment effectors.
    Roumenina L; Bureeva S; Kantardjiev A; Karlinsky D; Andia-Pravdivy JE; Sim R; Kaplun A; Popov M; Kishore U; Atanasov B
    J Mol Recognit; 2007; 20(5):405-15. PubMed ID: 17929239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions.
    Ji SR; Wu Y; Potempa LA; Liang YH; Zhao J
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):935-41. PubMed ID: 16456095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Existence of different but overlapping IgG- and IgM-binding sites on the globular domain of human C1q.
    Zlatarova AS; Rouseva M; Roumenina LT; Gadjeva M; Kolev M; Dobrev I; Olova N; Ghai R; Jensenius JC; Reid KB; Kishore U; Kojouharova MS
    Biochemistry; 2006 Aug; 45(33):9979-88. PubMed ID: 16906756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.